Adipose tissue ageing: implications for metabolic health and lifespan
Vaupel, J. W. Biodemography of human ageing. Nature 464, 536–542 (2010).
Google Scholar
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).
Google Scholar
Cypess, A. M. Reassessing human adipose tissue. N. Engl. J. Med. 386, 768–779 (2022).
Google Scholar
Ou, M. Y., Zhang, H., Tan, P. C., Zhou, S. B. & Li, Q. F. Adipose tissue aging: mechanisms and therapeutic implications. Cell Death Dis. 13, 300 (2022).
Google Scholar
Nguyen, T. T. & Corvera, S. Adipose tissue as a linchpin of organismal ageing. Nat. Metab. 6, 793–807 (2024).
Google Scholar
Schaum, N. et al. Ageing hallmarks exhibit organ-specific temporal signatures. Nature 583, 596–602 (2020).
Google Scholar
Zhou, Q. et al. A landscape of murine long non-coding RNAs reveals the leading transcriptome alterations in adipose tissue during aging. Cell Rep. 31, 107694 (2020).
Google Scholar
Scherer, P. E. The many secret lives of adipocytes: implications for diabetes. Diabetologia 62, 223–232 (2019).
Google Scholar
Sakers, A., De Siqueira, M. K., Seale, P. & Villanueva, C. J. Adipose-tissue plasticity in health and disease. Cell 185, 419–446 (2022).
Google Scholar
Maniyadath, B., Zhang, Q., Gupta, R. K. & Mandrup, S. Adipose tissue at single-cell resolution. Cell Metab. 35, 386–413 (2023).
Google Scholar
Auger, C. & Kajimura, S. Adipose tissue remodeling in pathophysiology. Annu. Rev. Pathol. 18, 71–93 (2023).
Google Scholar
Kuk, J. L., Saunders, T. J., Davidson, L. E. & Ross, R. Age-related changes in total and regional fat distribution. Ageing Res. Rev. 8, 339–348 (2009).
Google Scholar
Cero, C. et al. beta3-adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis. JCI Insight 6, e139160 (2021).
Google Scholar
Darcy, J. & Tseng, Y. H. ComBATing aging-does increased brown adipose tissue activity confer longevity? Geroscience 41, 285–296 (2019).
Google Scholar
Schwartz, R. S. et al. Body fat distribution in healthy young and older men. J. Gerontol. 45, M181–M185 (1990).
Google Scholar
Baarts, R. B. et al. Age- and sex-specific changes in visceral fat mass throughout the life-span. Obesity 31, 1953–1961 (2023).
Google Scholar
Yang, Y. C. et al. Life-course trajectories of body mass index from adolescence to old age: racial and educational disparities. Proc. Natl Acad. Sci. USA 118, e2020167118 (2021).
Google Scholar
Mott, J. W. et al. Relation between body fat and age in 4 ethnic groups. Am. J. Clin. Nutr. 69, 1007–1013 (1999).
Google Scholar
Ding, J. et al. Effects of birth cohort and age on body composition in a sample of community-based elderly. Am. J. Clin. Nutr. 85, 405–410 (2007).
Google Scholar
Reinders, I., Visser, M. & Schaap, L. Body weight and body composition in old age and their relationship with frailty. Curr. Opin. Clin. Nutr. Metab. Care 20, 11–15 (2017).
Google Scholar
Zhang, Z. et al. Dermal adipose tissue has high plasticity and undergoes reversible dedifferentiation in mice. J. Clin. Invest. 129, 5327–5342 (2019).
Google Scholar
Ezure, T., Amano, S. & Matsuzaki, K. Infiltration of subcutaneous adipose layer into the dermal layer with aging. Skin Res. Technol. 28, 311–316 (2022).
Google Scholar
Ofenheimer, A. et al. Reference values of body composition parameters and visceral adipose tissue (VAT) by DXA in adults aged 18-81 years-results from the LEAD cohort. Eur. J. Clin. Nutr. 74, 1181–1191 (2020).
Google Scholar
Justesen, J. et al. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2, 165–171 (2001).
Google Scholar
Zamboni, M. et al. Body composition changes in stable-weight elderly subjects: the effect of sex. Aging Clin. Exp. Res. 15, 321–327 (2003).
Google Scholar
Kuhn, J. P. et al. Pancreatic steatosis demonstrated at MR imaging in the general population: clinical relevance. Radiology 276, 129–136 (2015).
Google Scholar
Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85–97 (2011).
Google Scholar
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746–26749 (1995).
Google Scholar
Ye, R. et al. Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes beta-cell regeneration. eLife 3, e03851 (2014).
Google Scholar
Ryu, J. et al. Adiponectin alleviates diet-induced inflammation in the liver by suppressing MCP-1 expression and macrophage infiltration. Diabetes 70, 1303–1316 (2021).
Google Scholar
Coimbra, S., Brandao Proenca, J., Santos-Silva, A. & Neuparth, M. J. Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Biomed. Res. Int. 2014, 701915 (2014).
Google Scholar
Atzmon, G. et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J. Gerontol. A Biol. Sci. Med. Sci. 63, 447–453 (2008).
Google Scholar
Hotta, K. et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126–1133 (2001).
Google Scholar
Li, N. et al. Adiponectin preserves metabolic fitness during aging. eLife 10, e65108 (2021).
Google Scholar
Holland, W. L. et al. Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis. Mol. Metab. 6, 267–275 (2017).
Google Scholar
Frederich, R. C. et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 96, 1658–1663 (1995).
Google Scholar
Friedman, J. M. Leptin and the regulation of body weight. Keio J. Med. 60, 1–9 (2011).
Google Scholar
Ma, X. H. et al. Aging is associated with resistance to effects of leptin on fat distribution and insulin action. J. Gerontol. A Biol. Sci. Med. Sci. 57, B225–B231 (2002).
Google Scholar
Zhao, S. et al. Partial leptin reduction as an insulin sensitization and weight loss strategy. Cell Metab. 30, 706–719.e6 (2019).
Google Scholar
Gencer, B. et al. Association between resistin levels and cardiovascular disease events in older adults: the health, aging and body composition study. Atherosclerosis 245, 181–186 (2016).
Google Scholar
Steppan, C. M. et al. The hormone resistin links obesity to diabetes. Nature 409, 307–312 (2001).
Google Scholar
Acquarone, E., Monacelli, F., Borghi, R., Nencioni, A. & Odetti, P. Resistin: a reappraisal. Mech. Ageing Dev. 178, 46–63 (2019).
Google Scholar
Bozaoglu, K. et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148, 4687–4694 (2007).
Google Scholar
Lin, Y. et al. The chemerin-CMKLR1 axis limits thermogenesis by controlling a beige adipocyte/IL-33/type 2 innate immunity circuit. Sci. Immunol. 6, eabg9698 (2021).
Google Scholar
Hart, R. & Greaves, D. R. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J. Immunol. 185, 3728–3739 (2010).
Google Scholar
Parolini, S. et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109, 3625–3632 (2007).
Google Scholar
Grabner, G. F., Xie, H., Schweiger, M. & Zechner, R. Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat. Metab. 3, 1445–1465 (2021).
Google Scholar
Jaworski, K., Sarkadi-Nagy, E., Duncan, R. E., Ahmadian, M. & Sul, H. S. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1–G4 (2007).
Google Scholar
Li, E. et al. Control of lipolysis by a population of oxytocinergic sympathetic neurons. Nature 625, 175–180 (2024).
Google Scholar
Palmer, A. K. & Jensen, M. D. Metabolic changes in aging humans: current evidence and therapeutic strategies. J. Clin. Invest. 132, e158451 (2022).
Google Scholar
Gao, H. et al. Age-induced reduction in human lipolysis: a potential role for adipocyte noradrenaline degradation. Cell Metab. 32, 1–3 (2020).
Google Scholar
Lonnqvist, F., Nyberg, B., Wahrenberg, H. & Arner, P. Catecholamine-induced lipolysis in adipose tissue of the elderly. J. Clin. Invest. 85, 1614–1621 (1990).
Google Scholar
Markussen, L. K. et al. Lipolysis regulates major transcriptional programs in brown adipocytes. Nat. Commun. 13, 3956 (2022).
Google Scholar
Camell, C. D. et al. Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing. Nature 550, 119–123 (2017).
Google Scholar
Zhang, Z. et al. Dermal adipocytes contribute to the metabolic regulation of dermal fibroblasts. Exp. Dermatol. 30, 102–111 (2021).
Google Scholar
Yu, L. et al. IgG is an aging factor that drives adipose tissue fibrosis and metabolic decline. Cell Metab. 36, 793–807.e5 (2024).
Google Scholar
Cushman, S. W. & Wardzala, L. J. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J. Biol. Chem. 255, 4758–4762 (1980).
Google Scholar
Scherer, P. E. et al. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol. 127, 1233–1243 (1994).
Google Scholar
Fazakerley, D. J., Krycer, J. R., Kearney, A. L., Hocking, S. L. & James, D. E. Muscle and adipose tissue insulin resistance: malady without mechanism? J. Lipid Res. 60, 1720–1732 (2019).
Google Scholar
Halberg, N. et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell Biol. 29, 4467–4483 (2009).
Google Scholar
Zhang, L. et al. Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function. Am. J. Physiol. Endocrinol. Metab. 301, E599–E607 (2011).
Google Scholar
Crewe, C., An, Y. A. & Scherer, P. E. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J. Clin. Invest. 127, 74–82 (2017).
Google Scholar
Sun, K., Halberg, N., Khan, M., Magalang, U. J. & Scherer, P. E. Selective inhibition of hypoxia-inducible factor 1alpha ameliorates adipose tissue dysfunction. Mol. Cell Biol. 33, 904–917 (2013).
Google Scholar
Divoux, A. et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 59, 2817–2825 (2010).
Google Scholar
Miller, K. N. et al. Aging and caloric restriction impact adipose tissue, adiponectin, and circulating lipids. Aging Cell 16, 497–507 (2017).
Google Scholar
Laforest, S., Labrecque, J., Michaud, A., Cianflone, K. & Tchernof, A. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Crit. Rev. Clin. Lab. Sci. 52, 301–313 (2015).
Google Scholar
Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A. & Pratley, R. E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43, 1498–1506 (2000).
Google Scholar
Bluher, M. et al. Role of insulin action and cell size on protein expression patterns in adipocytes. J. Biol. Chem. 279, 31902–31909 (2004).
Google Scholar
Skurk, T., Alberti-Huber, C., Herder, C. & Hauner, H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 92, 1023–1033 (2007).
Google Scholar
Acosta, J. R. et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. Diabetologia 59, 560–570 (2016).
Google Scholar
Rajbhandari, P. et al. Single cell analysis reveals immune cell-adipocyte crosstalk regulating the transcription of thermogenic adipocytes. eLife 8, e49501 (2019).
Google Scholar
Sarvari, A. K. et al. Plasticity of epididymal adipose tissue in response to diet-induced obesity at single-nucleus resolution. Cell Metab. 33, 437–453.e5 (2021).
Google Scholar
Emont, M. P. et al. A single-cell atlas of human and mouse white adipose tissue. Nature 603, 926–933 (2022).
Google Scholar
Backdahl, J. et al. Spatial mapping reveals human adipocyte subpopulations with distinct sensitivities to insulin. Cell Metab. 33, 1869–1882.e6 (2021).
Google Scholar
Xie, L. et al. Single-nucleus RNA sequencing reveals heterogeneity among multiple white adipose tissue depots. Life Metab. 2, load045 (2023).
Google Scholar
Holman, C. D. et al. Aging impairs cold-induced beige adipogenesis and adipocyte metabolic reprogramming. eLife 12, RP87756 (2024).
Google Scholar
Hepler, C., Vishvanath, L. & Gupta, R. K. Sorting out adipocyte precursors and their role in physiology and disease. Genes Dev. 31, 127–140 (2017).
Google Scholar
Ghaben, A. L. & Scherer, P. E. Adipogenesis and metabolic health. Nat. Rev. Mol. Cell Biol. 20, 242–258 (2019).
Google Scholar
Burl, R. B. et al. Deconstructing adipogenesis induced by beta3-adrenergic receptor activation with single-cell expression profiling. Cell Metab. 28, 300–309 (2018).
Google Scholar
Merrick, D. et al. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science 364, eaav2501 (2019).
Google Scholar
Ferrero, R., Rainer, P. & Deplancke, B. Toward a consensus view of mammalian adipocyte stem and progenitor cell heterogeneity. Trends Cell Biol. 30, 937–950 (2020).
Google Scholar
Loft, A. et al. Towards a consensus atlas of human and mouse adipose tissue at single-cell resolution. Nat. Metab. 7, 875–894 (2025).
Google Scholar
Hepler, C. et al. Identification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice. eLife 7, e39636 (2018).
Google Scholar
Schwalie, P. C. et al. A stromal cell population that inhibits adipogenesis in mammalian fat depots. Nature 559, 103–108 (2018).
Google Scholar
Nguyen, H. P. et al. Aging-dependent regulatory cells emerge in subcutaneous fat to inhibit adipogenesis. Dev. Cell 56, 1437–1451.e3 (2021).
Google Scholar
Kotani, K. et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int. J. Obes. Relat. Metab. Disord. 18, 207–202 (1994).
Google Scholar
Kirkland, J. L. & Dobson, D. E. Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat tissue function. J. Am. Geriatr. Soc. 45, 959–967 (1997).
Google Scholar
Chaib, S., Tchkonia, T. & Kirkland, J. L. Cellular senescence and senolytics: the path to the clinic. Nat. Med. 28, 1556–1568 (2022).
Google Scholar
Kokai, L. E. et al. Adipose stem cell function maintained with age: an intra-subject study of long-term cryopreserved cells. Aesthet. Surg. J. 37, 454–463 (2017).
Google Scholar
Wang, G. et al. Distinct adipose progenitor cells emerging with age drive active adipogenesis. Science 388, eadj0430 (2025).
Google Scholar
Jacks, R. D. & Lumeng, C. N. Macrophage and T cell networks in adipose tissue. Nat. Rev. Endocrinol. 20, 50–61 (2024).
Google Scholar
Molofsky, A. B. et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535–549 (2013).
Google Scholar
Hildreth, A. D. et al. Single-cell sequencing of human white adipose tissue identifies new cell states in health and obesity. Nat. Immunol. 22, 639–653 (2021).
Google Scholar
Dahlquist, K. J. V. & Camell, C. D. Aging leukocytes and the inflammatory microenvironment of the adipose tissue. Diabetes 71, 23–30 (2022).
Google Scholar
Camell, C. D. et al. Aging induces an Nlrp3 inflammasome-dependent expansion of adipose B cells that impairs metabolic homeostasis. Cell Metab. 30, 1024–1039 (2019).
Google Scholar
Carey, A. et al. Age-associated accumulation of B cells promotes macrophage inflammation and inhibits lipolysis in adipose tissue during sepsis. Cell Rep. 43, 113967 (2024).
Google Scholar
Zhang, Z. et al. A panoramic view of cell population dynamics in mammalian aging. Science 387, eadn3949 (2025).
Google Scholar
Bruno, M. E. C. et al. Accumulation of gammadelta T cells in visceral fat with aging promotes chronic inflammation. Geroscience 44, 1761–1778 (2022).
Google Scholar
Wu, D. et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243–247 (2011).
Google Scholar
Brigger, D. et al. Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age. Nat. Metab. 2, 688–702 (2020).
Google Scholar
Goldberg, E. L. et al. IL-33 causes thermogenic failure in aging by expanding dysfunctional adipose ILC2. Cell Metab. 33, 2277–2287.e5 (2021).
Google Scholar
Shan, B. et al. Cold-responsive adipocyte progenitors couple adrenergic signaling to immune cell activation to promote beige adipocyte accrual. Genes Dev. 35, 1333–1338 (2021).
Google Scholar
Mahlakoiv, T. et al. Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33. Sci. Immunol. 4, eaax0416 (2019).
Google Scholar
Zeyda, M. et al. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int. J. Obes. 37, 658–665 (2013).
Google Scholar
Spallanzani, R. G. et al. Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors. Sci. Immunol. 4, eaaw3658 (2019).
Google Scholar
Vasanthakumar, A. et al. Sex-specific adipose tissue imprinting of regulatory T cells. Nature 579, 581–585 (2020).
Google Scholar
Cipolletta, D. et al. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549–553 (2012).
Google Scholar
Li, Y. et al. Insulin signaling establishes a developmental trajectory of adipose regulatory T cells. Nat. Immunol. 22, 1175–1185 (2021).
Google Scholar
Bapat, S. P. et al. Depletion of fat-resident Treg cells prevents age-associated insulin resistance. Nature 528, 137–141 (2015).
Google Scholar
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J. & Kirkland, J. L. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 123, 966–972 (2013).
Google Scholar
Petrocelli, J. J. et al. Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment. Aging Cell 22, e13936 (2023).
Google Scholar
Le Pelletier, L. et al. Metformin alleviates stress-induced cellular senescence of aging human adipose stromal cells and the ensuing adipocyte dysfunction. eLife 10, e62635 (2021).
Google Scholar
Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685–705 (2013).
Google Scholar
Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019).
Google Scholar
Wang, B. et al. An inducible p21-Cre mouse model to monitor and manipulate p21-highly-expressing senescent cells in vivo. Nat. Aging 1, 962–973 (2021).
Google Scholar
Palmer, A. K. et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell 18, e12950 (2019).
Google Scholar
Xu, M. et al. Targeting senescent cells enhances adipogenesis and metabolic function in old age. eLife 4, e12997 (2015).
Google Scholar
Zhou, Z. et al. Type 2 cytokine signaling in macrophages protects from cellular senescence and organismal aging. Immunity 57, 513–527 (2024).
Google Scholar
Han, H. S. et al. Impaired BCAA catabolism in adipose tissues promotes age-associated metabolic derangement. Nat. Aging 3, 982–1000 (2023).
Google Scholar
Zhu, Y. et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14, 644–658 (2015).
Google Scholar
Gasek, N. S., Kuchel, G. A., Kirkland, J. L. & Xu, M. Strategies for targeting senescent cells in human disease. Nat. Aging 1, 870–879 (2021).
Google Scholar
Zhang, L. et al. Cellular senescence: a key therapeutic target in aging and diseases. J. Clin. Investig. 132, e158450 (2022).
Google Scholar
Zhu, Y. et al. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans. eBioMedicine 77, 103912 (2022).
Google Scholar
He, Y. et al. PPARγ acetylation in adipocytes exacerbates BAT whitening and worsens age-associated metabolic dysfunction. Cells 12, 1424 (2023).
Google Scholar
Hamaoka, T. et al. Near-infrared time-resolved spectroscopy for assessing brown adipose tissue density in humans: a review. Front. Endocrinol. 11, 261 (2020).
Google Scholar
Saito, M. et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58, 1526–1531 (2009).
Google Scholar
Harms, M. & Seale, P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252–1263 (2013).
Google Scholar
Ikeda, K., Maretich, P. & Kajimura, S. The common and distinct features of brown and beige adipocytes. Trends Endocrinol. Metab. 29, 191–200 (2018).
Google Scholar
Cypess, A. M. et al. Emerging debates and resolutions in brown adipose tissue research. Cell Metab. 37, 12–33 (2025).
Google Scholar
Golozoubova, V. et al. Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold. FASEB J. 15, 2048–2050 (2001).
Google Scholar
Kazak, L. et al. Genetic depletion of adipocyte creatine metabolism inhibits diet-induced thermogenesis and drives obesity. Cell Metab. 26, 693 (2017).
Google Scholar
Bertholet, A. M. et al. Mitochondrial patch clamp of beige adipocytes reveals UCP1-positive and UCP1-negative cells both exhibiting futile creatine cycling. Cell Metab. 25, 811–822.e4 (2017).
Google Scholar
Ikeda, K. et al. UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis. Nat. Med. 23, 1454–1465 (2017).
Google Scholar
Kramarova, T. V. et al. Mitochondrial ATP synthase levels in brown adipose tissue are governed by the c-Fo subunit P1 isoform. FASEB J. 22, 55–63 (2008).
Google Scholar
Hanssen, M. J. et al. Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat. Med. 21, 863–865 (2015).
Google Scholar
Morrison, S. F., Madden, C. J. & Tupone, D. Central neural regulation of brown adipose tissue thermogenesis and energy expenditure. Cell Metab. 19, 741–756 (2014).
Google Scholar
Cypess, A. M. et al. Activation of human brown adipose tissue by a beta3-adrenergic receptor agonist. Cell Metab. 21, 33–38 (2015).
Google Scholar
Blondin, D. P. et al. Human brown adipocyte thermogenesis is driven by β2-AR stimulation. Cell Metab. 32, 287–300.e7 (2020).
Google Scholar
Rahbani, J. F. et al. ADRA1A-Gα(q) signalling potentiates adipocyte thermogenesis through CKB and TNAP. Nat. Metab. 4, 1459–1473 (2022).
Google Scholar
Chouchani, E. T., Kazak, L. & Spiegelman, B. M. New advances in adaptive thermogenesis: UCP1 and beyond. Cell Metab. 29, 27–37 (2019).
Google Scholar
Sun, Y. et al. Mitochondrial TNAP controls thermogenesis by hydrolysis of phosphocreatine. Nature 593, 580–585 (2021).
Google Scholar
Kazak, L. et al. Ablation of adipocyte creatine transport impairs thermogenesis and causes diet-induced obesity. Nat. Metab. 1, 360–370 (2019).
Google Scholar
Bunk, J. et al. The futile creatine cycle powers UCP1-independent thermogenesis in classical BAT. Nat. Commun. 16, 3221 (2025).
Google Scholar
Fedorenko, A., Lishko, P. V. & Kirichok, Y. Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 151, 400–413 (2012).
Google Scholar
Lee, P. et al. Brown adipose tissue exhibits a glucose-responsive thermogenic biorhythm in humans. Cell Metab. 23, 602–609 (2016).
Google Scholar
Yoneshiro, T. et al. BCAA catabolism in brown fat controls energy homeostasis through SLC25A44. Nature 572, 614–619 (2019).
Google Scholar
Weir, G. et al. Substantial metabolic activity of human brown adipose tissue during warm conditions and cold-induced lipolysis of local triglycerides. Cell Metab. 27, 1348–1355.e4 (2018).
Google Scholar
Mills, E. L. et al. Accumulation of succinate controls activation of adipose tissue thermogenesis. Nature 560, 102–106 (2018).
Google Scholar
Wang, Z. et al. Chronic cold exposure enhances glucose oxidation in brown adipose tissue. EMBO Rep. 21, e50085 (2020).
Google Scholar
Wang, G. X. et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat. Med. 20, 1436–1443 (2014).
Google Scholar
Hondares, E. et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J. Biol. Chem. 286, 12983–12990 (2011).
Google Scholar
Kong, X. et al. Brown adipose tissue controls skeletal muscle function via the secretion of myostatin. Cell Metab. 28, 631–643.e3 (2018).
Google Scholar
Whittle, A. J. et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149, 871–885 (2012).
Google Scholar
Sugimoto, S. et al. Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation. Nat. Metab. 4, 775–790 (2022).
Google Scholar
Lynes, M. D. et al. The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat. Med. 23, 631–637 (2017).
Google Scholar
Tajima, K. et al. Mitochondrial lipoylation integrates age-associated decline in brown fat thermogenesis. Nat. Metab. 1, 886–898 (2019).
Google Scholar
Cypess, A. M. et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509–1517 (2009).
Google Scholar
Becher, T. et al. Brown adipose tissue is associated with cardiometabolic health. Nat. Med. 27, 58–65 (2021).
Google Scholar
Bahler, L. et al. Differences in sympathetic nervous stimulation of brown adipose tissue between the young and old, and the lean and obese. J. Nucl. Med. 57, 372–377 (2016).
Google Scholar
Silva, G. D. N. & Amato, A. A. Thermogenic adipose tissue aging: mechanisms and implications. Front. Cell Dev. Biol. 10, 955612 (2022).
Google Scholar
Yoneshiro, T. et al. Impact of UCP1 and beta3AR gene polymorphisms on age-related changes in brown adipose tissue and adiposity in humans. Int. J. Obes. 37, 993–998 (2013).
Google Scholar
Feng, X. et al. Senescent immune cells accumulation promotes brown adipose tissue dysfunction during aging. Nat. Commun. 14, 3208 (2023).
Google Scholar
Song, A. et al. Low- and high-thermogenic brown adipocyte subpopulations coexist in murine adipose tissue. J. Clin. Invest. 130, 247–257 (2020).
Google Scholar
Sun, W. et al. snRNA-seq reveals a subpopulation of adipocytes that regulates thermogenesis. Nature 587, 98–102 (2020).
Google Scholar
Sun, W., Modica, S., Dong, H. & Wolfrum, C. Plasticity and heterogeneity of thermogenic adipose tissue. Nat. Metab. 3, 751–761 (2021).
Google Scholar
Lee, Y. H., Petkova, A. P., Konkar, A. A. & Granneman, J. G. Cellular origins of cold-induced brown adipocytes in adult mice. FASEB J. 29, 286–299 (2015).
Google Scholar
Shamsi, F. et al. Vascular smooth muscle-derived Trpv1+ progenitors are a source of cold-induced thermogenic adipocytes. Nat. Metab. 3, 485–495 (2021).
Google Scholar
Gabaldon, A. M., Florez-Duquet, M. L., Hamilton, J. S., McDonald, R. B. & Horwitz, B. A. Effects of age and gender on brown fat and skeletal muscle metabolic responses to cold in F344 rats. Am. J. Physiol. 268, R931–R941 (1995).
Google Scholar
Huang, Z. et al. Brown adipose tissue involution associated with progressive restriction in progenitor competence. Cell Rep. 39, 110575 (2022).
Google Scholar
Pan, X. X. et al. Senescent T cell induces brown adipose tissue “whitening” via secreting IFN-γ. Front. Cell Dev. Biol. 9, 637424 (2021).
Google Scholar
Wu, J. et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366–376 (2012).
Google Scholar
Jiang, Y., Berry, D. C. & Graff, J. M. Distinct cellular and molecular mechanisms for beta3 adrenergic receptor-induced beige adipocyte formation. eLife 6, e30329 (2017).
Google Scholar
Rui, L. Brown and beige adipose tissues in health and disease. Compr. Physiol. 7, 1281–1306 (2017).
Google Scholar
Ma, X., Xu, L., Gavrilova, O. & Mueller, E. Role of forkhead box protein A3 in age-associated metabolic decline. Proc. Natl Acad. Sci. USA 111, 14289–14294 (2014).
Google Scholar
Wang, W. et al. A PRDM16-driven metabolic signal from adipocytes regulates precursor cell fate. Cell Metab. 30, 174–189.e5 (2019).
Google Scholar
Wang, Q. et al. Post-translational control of beige fat biogenesis by PRDM16 stabilization. Nature 609, 151–158 (2022).
Google Scholar
Duteil, D. et al. Lsd1 prevents age-programed loss of beige adipocytes. Proc. Natl Acad. Sci. USA 114, 5265–5270 (2017).
Google Scholar
Majeed, Y. et al. SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways. Sci. Rep. 11, 8177 (2021).
Google Scholar
Pardo, P. S. & Boriek, A. M. SIRT1 regulation in ageing and obesity. Mech. Ageing Dev. 188, 111249 (2020).
Google Scholar
Altshuler-Keylin, S. et al. Beige adipocyte maintenance is regulated by autophagy-induced mitochondrial clearance. Cell Metab. 24, 402–419 (2016).
Google Scholar
Wu, R. et al. Genetically prolonged beige fat in male mice confers long-lasting metabolic health. Nat. Commun. 14, 2731 (2023).
Google Scholar
Park, J. et al. Estrogen counteracts age-related decline in beige adipogenesis through the NAMPT-regulated ER stress response. Nat. Aging 4, 839–853 (2024).
Google Scholar
Berry, D. C. et al. Cellular aging contributes to failure of cold-induced beige adipocyte formation in old mice and humans. Cell Metab. 25, 481 (2017).
Google Scholar
Chen, H. J., Meng, T., Gao, P. J. & Ruan, C. C. The role of brown adipose tissue dysfunction in the development of cardiovascular disease. Front. Endocrinol. 12, 652246 (2021).
Google Scholar
Gilani, A., Stoll, L., Homan, E. A. & Lo, J. C. Adipose signals regulating distal organ health and disease. Diabetes 73, 169–177 (2024).
Google Scholar
Younossi, Z. M. Non-alcoholic fatty liver disease — a global public health perspective. J. Hepatol. 70, 531–544 (2019).
Google Scholar
Castera, L., Friedrich-Rust, M. & Loomba, R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156, 1264–1281.e4 (2019).
Google Scholar
Mantovani, A. et al. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism 111S, 154170 (2020).
Google Scholar
Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537–2564 (2021).
Google Scholar
Ipsen, D. H., Lykkesfeldt, J. & Tveden-Nyborg, P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol. Life Sci. 75, 3313–3327 (2018).
Google Scholar
Nassir, F. NAFLD: mechanisms, treatments, and biomarkers. Biomolecules 12, 824 (2022).
Google Scholar
Saponaro, C. et al. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals. Liver Int. 42, 2418–2427 (2022).
Google Scholar
Micu, E. S. et al. Systemic and adipose tissue inflammation in NASH: correlations with histopathological aspects. Rom. J. Morphol. Embryol. 62, 509–515 (2021).
Google Scholar
Yamamuro, T. et al. Age-dependent loss of adipose Rubicon promotes metabolic disorders via excess autophagy. Nat. Commun. 11, 4150 (2020).
Google Scholar
Azzu, V., Vacca, M., Virtue, S., Allison, M. & Vidal-Puig, A. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology 158, 1899–1912 (2020).
Google Scholar
Martinez-Sanchez, C. et al. Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease. JHEP Rep. 5, 100830 (2023).
Google Scholar
Boesch, M. et al. Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH. J. Hepatol. 80, 397–408 (2024).
Google Scholar
Donia, T. & Khamis, A. Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges. Env. Sci. Pollut. Res. Int. 28, 34121–34153 (2021).
Google Scholar
Teixeira, T. M. et al. Activation of Nrf2-antioxidant signaling by 1,25-dihydroxycholecalciferol prevents leptin-induced oxidative stress and inflammation in human endothelial cells. J. Nutr. 147, 506–513 (2017).
Google Scholar
Wang, Z. V. & Scherer, P. E. Adiponectin, the past two decades. J. Mol. Cell Biol. 8, 93–100 (2016).
Google Scholar
Li, R. et al. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am. J. Physiol. Endocrinol. Metab. 293, E1703–E1708 (2007).
Google Scholar
Dekker, J. M. et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J. Clin. Endocrinol. Metab. 93, 1489–1496 (2008).
Google Scholar
Zhang, Y. et al. Adipocyte modulation of high-density lipoprotein cholesterol. Circulation 121, 1347–1355 (2010).
Google Scholar
Chui, P. C., Guan, H. P., Lehrke, M. & Lazar, M. A. PPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J. Clin. Invest. 115, 2244–2256 (2005).
Google Scholar
Schmidt, A. F. et al. Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes. Commun. Med. 3, 9 (2023).
Google Scholar
Mukama, T., Srour, B., Johnson, T., Katzke, V. & Kaaks, R. IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all causes in EPIC-Heidelberg. J. Clin. Endocrinol. Metab. 108, e1092–e1105 (2023).
Google Scholar
Oikonomou, E. K. & Antoniades, C. The role of adipose tissue in cardiovascular health and disease. Nat. Rev. Cardiol. 16, 83–99 (2019).
Google Scholar
O’Mara, A. E. et al. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J. Clin. Invest. 130, 2209–2219 (2020).
Google Scholar
Finlin, B. S. et al. The beta3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. J. Clin. Invest. 130, 2319–2331 (2020).
Google Scholar
Bartelt, A. et al. Brown adipose tissue activity controls triglyceride clearance. Nat. Med. 17, 200–205 (2011).
Google Scholar
Berbee, J. F. et al. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat. Commun. 6, 6356 (2015).
Google Scholar
Cypess, A. M. et al. Emerging debates and resolutions in brown adipose tissue research. Cell Metab. (2024).
Google Scholar
Queiroz, M. & Sena, C. M. Perivascular adipose tissue in age-related vascular disease. Ageing Res. Rev. 59, 101040 (2020).
Google Scholar
Gong, H. et al. Age-dependent tissue expression patterns of Sirt1 in senescence-accelerated mice. Mol. Med. Rep. 10, 3296–3302 (2014).
Google Scholar
Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).
Google Scholar
Zoncu, R., Efeyan, A. & Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21–35 (2011).
Google Scholar
Bluher, M., Kahn, B. B. & Kahn, C. R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572–574 (2003).
Google Scholar
Lee, D. J. W., Hodzic Kuerec, A. & Maier, A. B. Targeting ageing with rapamycin and its derivatives in humans: a systematic review. Lancet Healthy Longev. 5, e152–e162 (2024).
Google Scholar
Houde, V. P. et al. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59, 1338–1348 (2010).
Google Scholar
Lamming, D. W. et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638–1643 (2012).
Google Scholar
Johnston, O., Rose, C. L., Webster, A. C. & Gill, J. S. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J. Am. Soc. Nephrol. 19, 1411–1418 (2008).
Google Scholar
Shan, T. et al. Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice. Diabetologia 59, 1995–2004 (2016).
Google Scholar
de Cabo, R., Carmona-Gutierrez, D., Bernier, M., Hall, M. N. & Madeo, F. The search for antiaging interventions: from elixirs to fasting regimens. Cell 157, 1515–1526 (2014).
Google Scholar
Pontzer, H. et al. Daily energy expenditure through the human life course. Science 373, 808–812 (2021).
Google Scholar
Speakman, J. R. & Westerterp, K. R. Associations between energy demands, physical activity, and body composition in adult humans between 18 and 96 y of age. Am. J. Clin. Nutr. 92, 826–834 (2010).
Google Scholar
Corrales, P. et al. Long-term caloric restriction ameliorates deleterious effects of aging on white and brown adipose tissue plasticity. Aging Cell 18, e12948 (2019).
Google Scholar
Corrales, P. et al. microRNAs-mediated regulation of insulin signaling in white adipose tissue during aging: role of caloric restriction. Aging Cell 22, e13919 (2023).
Google Scholar
Yu, D. et al. Calorie-restriction-induced insulin sensitivity is mediated by adipose mTORC2 and not required for lifespan extension. Cell Rep. 29, 236–248.e3 (2019).
Google Scholar
Chinnapaka, S., Malekzadeh, H., Tirmizi, Z. & Ejaz, A. Caloric restriction mitigates age-associated senescence characteristics in subcutaneous adipose tissue-derived stem cells. Aging 16, 7535–7552 (2024).
Google Scholar
Suchacki, K. J. et al. The effects of caloric restriction on adipose tissue and metabolic health are sex- and age-dependent. eLife 12, e88080 (2023).
Google Scholar
Panda, S., Maier, G. & Villareal, D. T. Targeting energy intake and circadian biology to engage mechanisms of aging in older adults with obesity: calorie restriction and time-restricted eating. J. Gerontol. Ser. A 78, 79–85 (2023).
Google Scholar
Foretz, M., Guigas, B. & Viollet, B. Metformin: update on mechanisms of action and repurposing potential. Nat. Rev. Endocrinol. 19, 460–476 (2023).
Google Scholar
Barzilai, N., Crandall, J. P., Kritchevsky, S. B. & Espeland, M. A. Metformin as a tool to target aging. Cell Metab. 23, 1060–1065 (2016).
Google Scholar
Bharath, L. P. et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation. Cell Metab. 32, 44–55.e6 (2020).
Google Scholar
Cabreiro, F. et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153, 228–239 (2013).
Google Scholar
Wang, C. P., Lorenzo, C. & Espinoza, S. E. Frailty attenuates the impact of metformin on reducing mortality in older adults with type 2 diabetes. J. Endocrinol. Diabetes Obes. 2, 1031 (2014).
Google Scholar
Sundelin, E., Jensen, J. B., Jakobsen, S., Gormsen, L. C. & Jessen, N. Metformin biodistribution: a key to mechanisms of action? J. Clin. Endocrinol. Metab. 105, dgaa332 (2020).
Google Scholar
Duca, F. A. et al. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat. Med. 21, 506–511 (2015).
Google Scholar
Grycel, S. et al. Metformin treatment affects adipocytokine secretion and lipid composition in adipose tissues of diet-induced insulin-resistant rats. Nutrition 63-64, 126–133 (2019).
Google Scholar
Tokubuchi, I. et al. Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats. PLoS ONE 12, e0171293 (2017).
Google Scholar
Geerling, J. J. et al. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 63, 880–891 (2014).
Google Scholar
Holst, J. J. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 107, 1848–1855 (1994).
Google Scholar
Kusminski, C. M. et al. Transforming obesity: the advancement of multi-receptor drugs. Cell 187, 3829–3853 (2024).
Google Scholar
Day, J. W. et al. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat. Chem. Biol. 5, 749–757 (2009).
Google Scholar
Bossart, M. et al. Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist. Cell Metab. 34, 59–74.e10 (2022).
Google Scholar
Frias, J. P. et al. The sustained effects of a Dual GIP/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes. Cell Metab. 26, 343–352.e2 (2017).
Google Scholar
Davis, E. M. & Sandoval, D. A. Glucagon-like peptide-1: actions and influence on pancreatic hormone function. Compr. Physiol. 10, 577–595 (2020).
Google Scholar
Dossat, A. M., Lilly, N., Kay, K. & Williams, D. L. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J. Neurosci. 31, 14453–14457 (2011).
Google Scholar
Nauck, M. A. et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am. J. Physiol. 273, E981–E988 (1997).
Google Scholar
Gerstein, H. C. et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet 394, 121–130 (2019).
Google Scholar
Marso, S. P. et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311–322 (2016).
Google Scholar
Newsome, P. N. et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N. Engl. J. Med. 384, 1113–1124 (2021).
Google Scholar
Samms, R. J. et al. GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice. J. Clin. Investig. 131, e146353 (2021).
Google Scholar
Yu, X. et al. The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice. Cell Metab. 37, 187–204.e7 (2025).
Google Scholar
Beiroa, D. et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 63, 3346–3358 (2014).
Google Scholar
Gutierrez, A. D. et al. Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes. Cell Rep. Med. 3, 100813 (2022).
Google Scholar
Samms, R. J. et al. Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue. Mol. Metab. 64, 101550 (2022).
Google Scholar
Ida, S. et al. Effects of antidiabetic drugs on muscle mass in type 2 diabetes mellitus. Curr. Diabetes Rev. 17, 293–303 (2021).
Google Scholar
Sodhi, M., Rezaeianzadeh, R., Kezouh, A. & Etminan, M. Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA 330, 1795–1797 (2023).
Google Scholar
Chen, W., Cai, P., Zou, W. & Fu, Z. Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA adverse event reporting system database. Front. Endocrinol. 15, 1330936 (2024).
Google Scholar
Chang, J. et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22, 78–83 (2016).
Google Scholar
Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246–1256 (2018).
Google Scholar
Yousefzadeh, M. J. et al. Fisetin is a senotherapeutic that extends health and lifespan. eBioMedicine 36, 18–28 (2018).
Google Scholar
Cohn, R. L., Gasek, N. S., Kuchel, G. A. & Xu, M. The heterogeneity of cellular senescence: insights at the single-cell level. Trends Cell Biol. 33, 9–17 (2023).
Google Scholar
Saul, D. et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun. 13, 4827 (2022).
Google Scholar
Tao, W., Yu, Z. & Han, J. J. Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators. Cell Metab. 36, 1126–1143.e5 (2024).
Google Scholar
Wang, Q. A., Tao, C., Gupta, R. K. & Scherer, P. E. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat. Med. 19, 1338–1344 (2013).
Google Scholar
Vishvanath, L. et al. Pdgfrβ+ mural preadipocytes contribute to adipocyte hyperplasia induced by high-fat-diet feeding and prolonged cold exposure in adult mice. Cell Metab. 23, 350–359 (2016).
Google Scholar
de Paula, F. J. A. & Rosen, C. J. Marrow adipocytes: origin, structure, and function. Annu. Rev. Physiol. 82, 461–484 (2020).
Google Scholar
Horowitz, M. C. et al. Bone marrow adipocytes. Adipocyte 6, 193–204 (2017).
Google Scholar
de Araujo, I. M. et al. Marrow adipose tissue spectrum in obesity and type 2 diabetes mellitus. Eur. J. Endocrinol. 176, 21–30 (2017).
Google Scholar
Fazeli, P. K. et al. The dynamics of human bone marrow adipose tissue in response to feeding and fasting. JCI Insight 6, e138636 (2021).
Google Scholar
Cawthorn, W. P. et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab. 20, 368–375 (2014).
Google Scholar
Li, Z. et al. Lipolysis of bone marrow adipocytes is required to fuel bone and the marrow niche during energy deficits. eLife 11, e78496 (2022).
Google Scholar
Tratwal, J., Rojas-Sutterlin, S., Bataclan, C., Blum, S. & Naveiras, O. Bone marrow adiposity and the hematopoietic niche: a historical perspective of reciprocity, heterogeneity, and lineage commitment. Best Pract. Res. Clin. Endocrinol. Metab. 35, 101564 (2021).
Google Scholar
link
:max_bytes(150000):strip_icc()/7-Day-High-Protein-Mediterranean-Diet-Meal-Plan-Created-by-a-Dietitian-db620bb9aa584c4884cc4d3fe13b69be.jpg "7-Day High-Protein Mediterranean Diet Meal Plan")
